Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Gains of CASR, DAPK1, and KLK3--not yet described in gastric cancer--were present in the primary tumors, xenografts, and cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP543721.RAR7cFR_IRupXeYr3IuJnX5FKSFHDKZ8QCuXeOu8zEGhY130_assertion description "[Gains of CASR, DAPK1, and KLK3--not yet described in gastric cancer--were present in the primary tumors, xenografts, and cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP543721.RAR7cFR_IRupXeYr3IuJnX5FKSFHDKZ8QCuXeOu8zEGhY130_provenance.
• NP848253.RAUAuhGX-mB-IW_O2aM3p_0UKbkTv-Mg153J0NN7XeMlI130_assertion description "[Gains of CASR, DAPK1, and KLK3--not yet described in gastric cancer--were present in the primary tumors, xenografts, and cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848253.RAUAuhGX-mB-IW_O2aM3p_0UKbkTv-Mg153J0NN7XeMlI130_provenance.
• assertion description "[Gains of CASR, DAPK1, and KLK3--not yet described in gastric cancer--were present in the primary tumors, xenografts, and cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Gains of CASR, DAPK1, and KLK3--not yet described in gastric cancer--were present in the primary tumors, xenografts, and cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP707664.RAkpxSiNBg1n5sZU0gbk_uEGt-VWhHVyZybBUDBRC8y_g130_assertion description "[Gains of CASR, DAPK1, and KLK3--not yet described in gastric cancer--were present in the primary tumors, xenografts, and cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP707664.RAkpxSiNBg1n5sZU0gbk_uEGt-VWhHVyZybBUDBRC8y_g130_provenance.
• NP480122.RA6I6gNIGKbts5VjyT73KAfI0IvjkZApg6Cdxida0qL9w130_assertion description "[Gains of CASR, DAPK1, and KLK3--not yet described in gastric cancer--were present in the primary tumors, xenografts, and cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480122.RA6I6gNIGKbts5VjyT73KAfI0IvjkZApg6Cdxida0qL9w130_provenance.
• NP595295.RAte4canXXTZUgdxSSHDUoe1DmNdkiOXM885NgVRJpKsY130_assertion description "[Gains of CASR, DAPK1, and KLK3--not yet described in gastric cancer--were present in the primary tumors, xenografts, and cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP595295.RAte4canXXTZUgdxSSHDUoe1DmNdkiOXM885NgVRJpKsY130_provenance.
• NP443233.RA7A-qOfsAtU8GagcLcKXZQisJuZIXFDb68kbMBL9y2qU130_assertion description "[Gains of CASR, DAPK1, and KLK3--not yet described in gastric cancer--were present in the primary tumors, xenografts, and cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP443233.RA7A-qOfsAtU8GagcLcKXZQisJuZIXFDb68kbMBL9y2qU130_provenance.
• NP916790.RAgKZBnlloPn87azvUZN-k3ySvn89978mJ2MbTem_zNGk130_assertion description "[Gains of CASR, DAPK1, and KLK3--not yet described in gastric cancer--were present in the primary tumors, xenografts, and cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP916790.RAgKZBnlloPn87azvUZN-k3ySvn89978mJ2MbTem_zNGk130_provenance.
• NP563520.RA95MU1VckIJI25UiCe6ACG4C_TrMEarz0xqbK5mpNKoo130_assertion description "[Gains of CASR, DAPK1, and KLK3--not yet described in gastric cancer--were present in the primary tumors, xenografts, and cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP563520.RA95MU1VckIJI25UiCe6ACG4C_TrMEarz0xqbK5mpNKoo130_provenance.
• NP247730.RAQelxLIZozJlHSFPt3oI_8hfYjUnJzDPdlRf60IQl5Fc130_assertion description "[Gains of CASR, DAPK1, and KLK3--not yet described in gastric cancer--were present in the primary tumors, xenografts, and cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247730.RAQelxLIZozJlHSFPt3oI_8hfYjUnJzDPdlRf60IQl5Fc130_provenance.
• NP247920.RATaO8vcYInys7U5culzoSOtaWVuJNpv0lzLaan4Jbo4k130_assertion description "[Gains of CASR, DAPK1, and KLK3--not yet described in gastric cancer--were present in the primary tumors, xenografts, and cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247920.RATaO8vcYInys7U5culzoSOtaWVuJNpv0lzLaan4Jbo4k130_provenance.
• NP526474.RAdCotbBynfVQ0VttWMBElwvffL4A3JJP3DhY_aSy2ZBA130_assertion description "[Gains of CASR, DAPK1, and KLK3--not yet described in gastric cancer--were present in the primary tumors, xenografts, and cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP526474.RAdCotbBynfVQ0VttWMBElwvffL4A3JJP3DhY_aSy2ZBA130_provenance.
• NP600305.RAkovdxTmCkJ0zRh2Ak1x9T9c04rD58Wda1TbU6bjCIVE130_assertion description "[Gains of CASR, DAPK1, and KLK3--not yet described in gastric cancer--were present in the primary tumors, xenografts, and cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP600305.RAkovdxTmCkJ0zRh2Ak1x9T9c04rD58Wda1TbU6bjCIVE130_provenance.
• NP526431.RAHRzi4iU4aBDs4D5F2LKkD5vAXa1EkxVgahQGbTiuOic130_assertion description "[Gains of CASR, DAPK1, and KLK3--not yet described in gastric cancer--were present in the primary tumors, xenografts, and cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP526431.RAHRzi4iU4aBDs4D5F2LKkD5vAXa1EkxVgahQGbTiuOic130_provenance.
• NP600309.RAJNeK75F0NuSjpllelMzjkCXfOz7qV0lY1_yisdpQ8o8130_assertion description "[Gains of CASR, DAPK1, and KLK3--not yet described in gastric cancer--were present in the primary tumors, xenografts, and cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP600309.RAJNeK75F0NuSjpllelMzjkCXfOz7qV0lY1_yisdpQ8o8130_provenance.
• NP600307.RA0Q2B9SckL2SuS3kMHpbOayqmD_xZ_ftNLCrcw1nTDvc130_assertion description "[Gains of CASR, DAPK1, and KLK3--not yet described in gastric cancer--were present in the primary tumors, xenografts, and cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP600307.RA0Q2B9SckL2SuS3kMHpbOayqmD_xZ_ftNLCrcw1nTDvc130_provenance.
• NP600308.RA-tw_K_Tv7mVfWhK8rFPQQDUXohnV0ry6Ovz9yZPtK4U130_assertion description "[Gains of CASR, DAPK1, and KLK3--not yet described in gastric cancer--were present in the primary tumors, xenografts, and cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP600308.RA-tw_K_Tv7mVfWhK8rFPQQDUXohnV0ry6Ovz9yZPtK4U130_provenance.